{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T19:28:55Z","timestamp":1771702135025,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,6,1]]},"DOI":"10.1038\/bmt.2008.53","type":"journal-article","created":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T04:09:50Z","timestamp":1213157390000},"page":"S39-S42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Early complications following haematopoietic SCT in children"],"prefix":"10.1038","volume":"41","author":[{"given":"M","family":"Miano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Dini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bordigoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the EBMT Paediatric Working Party","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,11]]},"reference":[{"key":"BFbmt200853_CR1","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB . Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171\u20131181.","journal-title":"Hepatology"},{"key":"BFbmt200853_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00688324","volume":"37","author":"G Vassal","year":"1996","unstructured":"Vassal G, Koscielny S, Challine D, Valteau-Couanet D, Boland I, Deroussent A et al. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1996; 37: 247\u2013253.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFbmt200853_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","volume":"22","author":"S Hasegawa","year":"1998","unstructured":"Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Bone Marrow Transplant 1998; 22: 1191\u20131197.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200853_CR4","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W, Vernant JP, Tomas JF, Hagglund H et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998; 92: 3599\u20133604.","journal-title":"Blood"},{"key":"BFbmt200853_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S1083-8791(99)70006-6","volume":"5","author":"JL Lee","year":"1999","unstructured":"Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB . Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. Biol Marrow Transplant 1999; 5: 306\u2013315.","journal-title":"Biol Marrow Transplant"},{"key":"BFbmt200853_CR6","first-page":"124A","volume":"98","author":"EA Stadtmauer","year":"2001","unstructured":"Stadtmauer EA, Larson RA, Sievers E, Estey E, Lowenberg B, Leopold LH et al. Analysis of predisposing factors for hepatic veno-occlusive disease after treatment with gemtuzumab ozagamicin (Mylotarg, CMA-676). Blood 2001; 98: 124A.","journal-title":"Blood"},{"key":"BFbmt200853_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, Mc Donald GB . Toxic injury to hepatic sinusoid: Sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27\u201342.","journal-title":"Semin Liver Dis"},{"key":"BFbmt200853_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/10428199909093722","volume":"33","author":"C Salat","year":"1999","unstructured":"Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Penovici M et al. The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation. Leuk Lymphoma 1999; 33: 25\u201332.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt200853_CR9","first-page":"471","volume":"11","author":"B Rio","year":"1993","unstructured":"Rio B, Bauduer F, Arrago JP, Zittoun R . N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplant 1993; 11: 471\u2013472.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200853_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/0140-6736(93)91646-4","volume":"342","author":"M Eltumi","year":"1993","unstructured":"Eltumi M, Trivedi P, Hobbs JR, Portmann B, Cheeseman P, Downie C et al. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet 1993; 342: 518\u2013521.","journal-title":"Lancet"},{"key":"BFbmt200853_CR11","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1182\/blood.V83.10.3036.3036","volume":"83","author":"M Heikinheimo","year":"1994","unstructured":"Heikinheimo M, Halila R, Fasth A . Serum procollagen type III is an early and sensitive marker for veno- occlusive disease of the liver in children undergoing bone marrow transplantation. Blood 1994; 83: 3036\u20133040.","journal-title":"Blood"},{"key":"BFbmt200853_CR12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000; 111: 1122\u20131129.","journal-title":"Br J Haematol"},{"key":"BFbmt200853_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al., European Group for Blood and Marrow Transplantation; European LeukemiaNet. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007; 92: 95\u2013100.","journal-title":"Haematologica"},{"key":"BFbmt200853_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1703710","volume":"30","author":"AS Daly","year":"2002","unstructured":"Daly AS, Xenocostas A, Lipton JH . Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002; 30: 709\u2013715. Review.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200853_CR15","first-page":"247","volume":"15","author":"ZR Zeigler","year":"1995","unstructured":"Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS . Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995; 15: 247\u2013253.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200853_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","volume":"82","author":"C Uderzo","year":"2006","unstructured":"Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M et al. Risk factors and severe outcome in Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation 2006; 82: 638\u2013644.","journal-title":"Transplantation"},{"key":"BFbmt200853_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","volume":"27","author":"TR Spitzer","year":"2001","unstructured":"Spitzer TR . Engraftment syndrome following haematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893\u2013898.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200853_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbmt.2005.06.007","volume":"11","author":"E Gorczynska","year":"2005","unstructured":"Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 797\u2013804.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt200853_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/sj.bmt.1704252","volume":"32","author":"S Cesaro","year":"2003","unstructured":"Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003; 32: 925\u2013931.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200853_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1083-8791(03)00269-6","volume":"9","author":"GA Hale","year":"2003","unstructured":"Hale GA, Rochester RJ, Heslop HE, Krance RA, Gingrich JR, Benaim E et al. Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant 2003; 9: 698\u2013705.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt200853_CR21","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1182\/blood.V98.6.1971","volume":"98","author":"AY Leung","year":"2001","unstructured":"Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL . Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971\u20131978.","journal-title":"Blood"},{"key":"BFbmt200853_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/0090-4295(82)90633-1","volume":"20","author":"MJ Droller","year":"1982","unstructured":"Droller MJ, Saral R, Santos G . Prevention of cyclophosphamide-induced hemorragic cystitis. Urology 1982; 20: 256\u2013258.","journal-title":"Urology"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt200853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt200853","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt200853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T14:34:41Z","timestamp":1659105281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt200853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":22,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2008,6,1]]}},"alternative-id":["BFbmt200853"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.53","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,1]]},"assertion":[{"value":"11 June 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}